Last update Dec. 4, 2020
Low Risk
Suggestions made at e-lactancia are done by APILAM team of health professionals, and are based on updated scientific publications. It is not intended to replace the relationship you have with your doctor but to compound it. The pharmaceutical industry contraindicates breastfeeding, mistakenly and without scientific reasons, in most of the drug data sheets.
Your contribution is essential for this service to continue to exist. We need the generosity of people like you who believe in the benefits of breastfeeding.
Thank you for helping to protect and promote breastfeeding.
Clofazimine is also known as
Clofazimine in other languages or writings:
Main tradenames from several countries containing Clofazimine in its composition:
Write us at elactancia.org@gmail.com
e-lactancia is a resource recommended by AELAMA of Spain
Would you like to recommend the use of e-lactancia? Write to us at corporate mail of APILAM
An antimicrobial indicated in the treatment of leprosy.
Daily oral administration over several months.
It is excreted in breastmilk in an amount that could be significant (Venkatesan 1997), but no adverse effects have been observed in infants whose mothers were taking it, with the exception of being able to cause a reddish discoloration of the skin of infants, reversible at the end of treatment. (Ozturk 2017, WHO 2002).
May turn milk bright pink (Waters 1969).
Known alternatives with faster elimination and less excretion in breastmilk should be considered, especially during the neonatal period and in cases of prematurity.